- April 20, 2022
- Vineti
- Posted in Company Updates
sedApta Group and Vineti partner to develop integrated digital supply chain and manufacturing solution for cell and gene therapies
The sedApta Group, a global software provider specialized in innovative IT solutions for digital Supply Chain and Smart Manufacturing, and Vineti, the provider of the…
- March 25, 2022
- Marc Puich
- Posted in Cell and Gene Therapy
Gene therapies – simpler doesn’t mean simple
Cell and gene therapies are produced and delivered via the most complex workflows in the history of medicine. Among those workflows, though, there’s a range…
- March 23, 2022
- Vineti
- Posted in Company Updates
Vineti secures new patent from USPTO for individualized medicine platform
SAN FRANCISCO, March ##, 2022 (GLOBE NEWSWIRE) – Vineti, Inc., the provider of the leading digital platform of record for cell and gene therapies, today…
- March 18, 2022
- Louise Pacini
- Posted in Cell and Gene Therapy
Cell and gene therapies – new treatments, new value
At the recent Gene Therapy for Rare Disorders conference in Boston, I had the opportunity to discuss thoughts on value with an audience dedicated to…
- March 4, 2022
- Vineti
- Posted in Company Updates
Vineti Appoints Ann Klein as Chief Executive Officer
Vineti, Inc., the provider of the leading digital platform of record for personalized therapeutics, today announced the successful completion of its Service Organization Control (SOC®)…
- February 2, 2022
- Subbu Viswanathan
- Posted in Cloud Technology
Vineti’s Personalized Therapy Management® (PTM) solution meets rigorous standards: Service Organization Control (SOC®) 2 Type II compliance audit
Vineti, developer of the leading digital platform of record for personalized therapeutics, today announced a new Integration Suite as a cornerstone of its Personalized Therapy…
- January 27, 2022
- Vineti
- Posted in Company Updates
Vineti achieves SOC2 Type II compliance
Vineti, Inc., the provider of the leading digital platform of record for personalized therapeutics, today announced the successful completion of its Service Organization Control (SOC®)…
- January 10, 2022
- Vineti
- Posted in Company Updates
Vineti introduces new PTM® Integration Suite: purpose-built connectivity and interoperability for cell and gene therapies
Vineti, developer of the leading digital platform of record for personalized therapeutics, today announced a new Integration Suite as a cornerstone of its Personalized Therapy…
- December 8, 2021
- Vineti
- Posted in Company Updates
Be The Match BioTherapies® and Vineti collaborate to develop innovative, integrated supply chain management solutions for cell and gene therapies
MINNEAPOLIS, Minn. and SAN FRANCISCO, Calif, December 08, 2021 - Be The Match BioTherapies®, an organization offering solutions for companies developing and commercializing cell and…
- November 11, 2021
- Vineti
- Posted in Company Updates
Must-watch: Vineti’s Women in Tech panel discussion
ers across healthcare and technology! The event was moderated by Kat Noren, SVP of People and Places at Vineti, with panelists including Heidi Rozen, Partner…
- October 19, 2021
- Vineti
- Posted in Company Updates
Autolomous and Vineti form strategic partnership to deliver end to end supply chain management solutions for cell and gene therapy sector
Autolomous LTD, the market leading developer of critical manufacturing management systems for cell and gene therapies, and Vineti, a provider of leading digital enterprise platforms…
- October 13, 2021
- Vineti
- Posted in Company Updates
Körber and Vineti Announce Partnership to Provide Improved Manufacturing Performance and Visibility Globally for Cell and Gene-Based Therapies
Körber, the leading MES supplier for pharma and biotech, and Vineti, the world’s only enterprise software platform supporting supply chain orchestration for clinical and commercial…